Keywords: tkt, seek, ok, replagal, transkaryotic, therapies, revealed

TKT will not seek US OK for Replagal

Article | 19 January 2004

Print This

Transkaryotic Therapies has revealed that it is abandoning efforts to win US Food and Drug Administration approval of its Replagal ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in